https://old.journalforclinicalstudies.com/bavarian-nordic-announces-initiation-of-phase-1-2a-clinical-trial-of-therapeutic-hpv-vaccine-regimen-in-collaboration-with-janssen/ 2019-02-28T10:01:59+00:00 https://old.journalforclinicalstudies.com/offering-mercks-experimental-ebola-vaccine-to-pregnant-women-is-a-risky-but-necessary-move-says-globaldata/ 2019-02-28T09:59:23+00:00 https://old.journalforclinicalstudies.com/clinerion-partners-with-medsoft-on-expanding-clinical-research-in-georgia/ 2019-02-28T09:51:49+00:00 https://old.journalforclinicalstudies.com/setting-standards-achieving-workforce-excellence/ 2019-02-28T09:49:26+00:00 https://old.journalforclinicalstudies.com/minoryx-therapeutics-receives-approval-from-spanish-regulatory-agency-to-initiate-phase-2-study-in-friedreichs-ataxia/ 2019-02-28T09:47:53+00:00 https://old.journalforclinicalstudies.com/clinical-trial-researchers-can-initiate-advance-care-planning-discussions-to-help-cancer-patients/ 2019-02-20T11:19:30+00:00 https://old.journalforclinicalstudies.com/with-positive-phase-3-intercept-to-file-nash-drug-for-approval-while-inventiva-faces-a-setback/ 2019-02-20T11:17:16+00:00 https://old.journalforclinicalstudies.com/boehringer-ingelheim-canada-ltd-and-ibm-canada-announce-first-of-its-kind-collaboration-to-integrate-blockchain-technology-into-clinical-trials-2/ 2019-02-20T11:14:27+00:00 https://old.journalforclinicalstudies.com/use-of-clinical-apps-significantly-improves-quality-of-cardiovascular-care-2/ 2019-02-20T11:12:26+00:00 https://old.journalforclinicalstudies.com/ochsner-health-system-and-pfizer-partner-to-develop-innovative-models-for-clinical-trials-2/ 2019-02-20T11:11:09+00:00 https://old.journalforclinicalstudies.com/orions-and-bayers-darolutamide-shows-substantial-efficacy-and-a-favourable-safety-profile-in-the-treatment-of-prostate-cancer-in-the-aramis-trial-2/ 2019-02-20T11:08:51+00:00 https://old.journalforclinicalstudies.com/astrazenecas-medi8897-has-potential-to-challenge-existing-rsv-products-with-substantially-improved-efficacy-says-globaldata-2/ 2019-02-20T10:58:26+00:00 https://old.journalforclinicalstudies.com/new-clinerion-and-citeline-partnership-simplifies-and-strengthens-matchmaking-between-clinical-researchers-and-qualified-patients-2/ 2019-02-20T10:56:30+00:00 https://old.journalforclinicalstudies.com/our-brains-indicate-how-well-depression-will-respond-to-treatment-2/ 2019-02-20T10:54:11+00:00 https://old.journalforclinicalstudies.com/quanticate-appoints-paula-finch-as-senior-vice-president-project-delivery-2/ 2019-02-20T10:50:42+00:00 https://old.journalforclinicalstudies.com/alzprotect-on-track-for-a-phase-2-entry-in-2019-for-its-drug-candidate-azp2006-2/ 2019-02-20T10:49:38+00:00 https://old.journalforclinicalstudies.com/despite-phase-iii-failure-gileads-selonsertib-may-still-have-place-in-nash-combination-therapy-strategy-says-globaldata-2/ 2019-02-20T10:48:40+00:00 https://old.journalforclinicalstudies.com/owlstone-medical-partners-with-shanghai-renji-hospital-to-pioneer-breath-biopsy-lung-cancer-trial-in-china-2/ 2019-02-20T10:46:46+00:00 https://old.journalforclinicalstudies.com/merck-plans-trio-of-phase-3-keytruda-studies-in-prostate-cancer/ 2019-02-20T10:29:20+00:00 https://old.journalforclinicalstudies.com/intercept-nash-drug-succeeds-in-fields-first-positive-phase-3-trial/ 2019-02-20T10:24:39+00:00 https://old.journalforclinicalstudies.com/boehringer-ingelheim-canada-ltd-and-ibm-canada-announce-first-of-its-kind-collaboration-to-integrate-blockchain-technology-into-clinical-trials/ 2019-02-20T10:18:34+00:00 https://old.journalforclinicalstudies.com/use-of-clinical-apps-significantly-improves-quality-of-cardiovascular-care/ 2019-02-20T10:16:06+00:00 https://old.journalforclinicalstudies.com/ochsner-health-system-and-pfizer-partner-to-develop-innovative-models-for-clinical-trials/ 2019-02-20T10:14:36+00:00 https://old.journalforclinicalstudies.com/orions-and-bayers-darolutamide-shows-substantial-efficacy-and-a-favourable-safety-profile-in-the-treatment-of-prostate-cancer-in-the-aramis-trial/ 2019-02-20T10:06:54+00:00 https://old.journalforclinicalstudies.com/astrazenecas-medi8897-has-potential-to-challenge-existing-rsv-products-with-substantially-improved-efficacy-says-globaldata/ 2019-02-20T10:04:08+00:00 https://old.journalforclinicalstudies.com/mercks-keytruda-set-to-become-new-standard-of-care-for-renal-cancer-patient-population-after-gaining-edge-over-competitors-says-globaldata-2/ 2019-02-20T10:02:59+00:00 https://old.journalforclinicalstudies.com/new-clinerion-and-citeline-partnership-simplifies-and-strengthens-matchmaking-between-clinical-researchers-and-qualified-patients/ 2019-02-20T10:01:57+00:00 https://old.journalforclinicalstudies.com/our-brains-indicate-how-well-depression-will-respond-to-treatment/ 2019-02-20T10:00:43+00:00 https://old.journalforclinicalstudies.com/mercks-keytruda-set-to-become-new-standard-of-care-for-renal-cancer-patient-population-after-gaining-edge-over-competitors-says-globaldata/ 2019-02-20T09:58:41+00:00 https://old.journalforclinicalstudies.com/quanticate-appoints-paula-finch-as-senior-vice-president-project-delivery/ 2019-02-20T09:52:29+00:00 https://old.journalforclinicalstudies.com/despite-phase-iii-failure-gileads-selonsertib-may-still-have-place-in-nash-combination-therapy-strategy-says-globaldata/ 2019-02-20T09:51:22+00:00 https://old.journalforclinicalstudies.com/alzprotect-on-track-for-a-phase-2-entry-in-2019-for-its-drug-candidate-azp2006/ 2019-02-20T09:37:52+00:00 https://old.journalforclinicalstudies.com/owlstone-medical-partners-with-shanghai-renji-hospital-to-pioneer-breath-biopsy-lung-cancer-trial-in-china/ 2019-02-20T09:36:37+00:00 https://old.journalforclinicalstudies.com/shimmer-launches-verisense-wearable-sensor-platform-for-clinical-trials/ 2019-02-19T16:29:49+00:00 https://old.journalforclinicalstudies.com/approving-jjs-new-depression-drug-would-be-an-unusual-move-for-the-fda/ 2019-02-14T10:28:44+00:00 https://old.journalforclinicalstudies.com/merck-kidney-cancer-data-impresses-putting-pressure-on-bristol-myers/ 2019-02-14T10:22:15+00:00 https://old.journalforclinicalstudies.com/stem-cell-transplant-slows-down-ms-progression/ 2019-02-14T09:48:18+00:00 https://old.journalforclinicalstudies.com/new-drug-shows-promise-against-several-aggressive-cancers/ 2019-02-14T09:45:46+00:00 https://old.journalforclinicalstudies.com/audion-therapeutics-and-regain-consortium-announce-positive-phase-i-results-in-patients-with-sensorineural-hearing-loss-2/ 2019-02-14T09:39:37+00:00 https://old.journalforclinicalstudies.com/orion-and-bayer-jointly-present-new-data-in-prostate-cancer-from-the-darolutamide-aramis-study/ 2019-02-14T09:37:47+00:00 https://old.journalforclinicalstudies.com/sharp-enhances-irt-solution-with-latest-investment-2/ 2019-02-14T09:35:58+00:00 https://old.journalforclinicalstudies.com/crf-bracket-becomes-a-leading-employer-in-romania-two-years-after-establishing-office-as-demand-for-trustworthy-global-support-of-eclinical-solutions-continues-to-grow-2/ 2019-02-14T09:35:00+00:00 https://old.journalforclinicalstudies.com/fda-approves-cablivi-caplacizumab-yhdp-the-first-nanobody-based-medicine-for-adults-with-acquired-thrombotic-thrombocytopenic-purpura-attp/ 2019-02-14T09:33:31+00:00 https://old.journalforclinicalstudies.com/from-patient-centric-technologies-to-clinical-trial-supply-chain-management-crf-bracket-moves-clinical-trials-forward-at-the-10th-annual-scope-summit/ 2019-02-14T09:28:51+00:00 https://old.journalforclinicalstudies.com/development-progress-in-2018-for-acute-ischemic-stroke-drugs-will-fuel-market-growth-says-globaldata/ 2019-02-14T09:27:06+00:00 https://old.journalforclinicalstudies.com/brand-new-type-of-cancer-drug-has-potential-to-fill-unmet-needs-in-oncology-market-says-globaldata/ 2019-02-14T09:25:32+00:00 https://old.journalforclinicalstudies.com/4-of-the-top-7-global-cros-have-selected-veeva-vault-etmf-as-their-enterprise-standard/ 2019-02-14T09:24:46+00:00 https://old.journalforclinicalstudies.com/sgs-to-conduct-its-first-malaria-human-challenge-trial-in-belgium/ 2019-02-14T09:19:36+00:00 https://old.journalforclinicalstudies.com/despite-recent-setbacks-the-ophthalmology-market-still-offers-vast-potential-says-globaldata/ 2019-02-12T16:08:06+00:00 https://old.journalforclinicalstudies.com/a-preliminary-clinical-trial-shows-that-stem-cell-transplantation-along-with-a-tolerable-dose-of-chemotherapy-is-safe-and-more-effective-at-slowing-down-multiple-sclerosis-than-other-existing-therap/ 2019-02-07T10:54:14+00:00 https://old.journalforclinicalstudies.com/us-fda-grants-breakthrough-therapy-designation-for-potential-next-generation-rsv-medicine-medi8897/ 2019-02-07T10:32:34+00:00 https://old.journalforclinicalstudies.com/fda-approves-first-therapy-for-the-treatment-of-adult-patients-with-a-rare-blood-clotting-disorder/ 2019-02-07T10:30:07+00:00 https://old.journalforclinicalstudies.com/macrogenics-breast-cancer-drug-tops-herceptin-in-late-stage-trial/ 2019-02-07T10:17:03+00:00 https://old.journalforclinicalstudies.com/chmp-recommends-approval-of-praluent-alirocumab-to-reduce-cardiovascular-risk-in-people-with-established-atherosclerotic-cardiovascular-disease/ 2019-02-07T10:15:40+00:00 https://old.journalforclinicalstudies.com/weak-q4-results-and-ms-portfolio-should-be-cause-for-concern-for-biogen-says-globaldata/ 2019-02-07T10:09:42+00:00 https://old.journalforclinicalstudies.com/new-report-calls-for-nhs-workforce-culture-to-be-measured-and-reported-to-the-cqc-and-nhs-improvement/ 2019-02-07T10:04:11+00:00 https://old.journalforclinicalstudies.com/isatuximab-phase-3-trial-meets-primary-endpoint-of-prolonging-progression-free-survival-in-patients-with-relapsed-refractory-multiple-myeloma/ 2019-02-07T10:02:43+00:00 https://old.journalforclinicalstudies.com/audion-therapeutics-and-regain-consortium-announce-positive-phase-i-results-in-patients-with-sensorineural-hearing-loss/ 2019-02-07T09:59:57+00:00 https://old.journalforclinicalstudies.com/crf-bracket-becomes-a-leading-employer-in-romania-two-years-after-establishing-office-as-demand-for-trustworthy-global-support-of-eclinical-solutions-continues-to-grow/ 2019-02-07T09:56:33+00:00 https://old.journalforclinicalstudies.com/fda-approves-cablivi-caplacizumab-yhdp-the-first-nanobody-based-medicine-for-adults-with-acquired-thrombotic-thrombocytopenic-purpura-attp%ef%bb%bf/ 2019-02-07T09:55:09+00:00 https://old.journalforclinicalstudies.com/sharp-enhances-irt-solution-with-latest-investment/ 2019-02-07T09:52:57+00:00 https://old.journalforclinicalstudies.com/pci-pharma-services-announces-bottling-line-expansion-to-support-customer-needs/ 2019-02-06T10:34:56+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2019/02/PCI-expands-Bottling-capacity.jpeg https://old.journalforclinicalstudies.com/hello-world/ 2019-01-29T13:23:46+00:00 https://old.journalforclinicalstudies.com/clinical-testing-begins-temperature-stable-experimental-tuberculosis-vaccine/ 2019-01-24T10:30:35+00:00 https://old.journalforclinicalstudies.com/potential-restasis-rival-falls-short-head-head-study/ 2019-01-24T10:21:06+00:00 https://old.journalforclinicalstudies.com/sorrento-shows-fast-durable-arthritis-pain-relief-spicy-injection-early-study/ 2019-01-24T10:15:48+00:00 https://old.journalforclinicalstudies.com/final-verdict-finasteride-safe-effective-prevention-prostate-cancer/ 2019-01-24T10:12:00+00:00 https://old.journalforclinicalstudies.com/sharp-completes-relocation-23-million-clinical-services-facility-bethlehem/ 2019-01-24T10:03:48+00:00 https://old.journalforclinicalstudies.com/pharmaseal-launches-engilityo-ctms-innovative-clinical-trial-management-platform-unified-governance/ 2019-01-24T10:02:06+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2019/01/PHARMASEAL-Team-e1548324095603.jpg https://old.journalforclinicalstudies.com/iddi-starts-collaborative-research-ground-breaking-statistical-method-individualization-therapy/ 2019-01-24T09:58:57+00:00 https://old.journalforclinicalstudies.com/100-year-history-greens-1919-2019/ 2019-01-23T13:11:47+00:00 https://old.journalforclinicalstudies.com/pci-pharma-services-announces-20-million-expansion-biotech-technologies-including-advanced-injectable-delivery-forms-2/ 2019-01-22T11:05:00+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2019/01/PCI-Syringe-assembly-1-scaled.jpg https://old.journalforclinicalstudies.com/wp-content/uploads/2019/01/PCI-invests-in-automated-assembly-of-autoinjectors-300dpi-1.jpg https://old.journalforclinicalstudies.com/niche-biometric-cro-launches-dedicated-pharmacovigilance-business/ 2019-01-17T14:08:59+00:00 https://old.journalforclinicalstudies.com/new-machine-learning-algorithms-identify-early-symptoms-urinary-tract-infections/ 2019-01-17T10:47:02+00:00 https://old.journalforclinicalstudies.com/aptinyx-stung-pain-drugs-mid-stage-miss/ 2019-01-17T10:34:16+00:00 https://old.journalforclinicalstudies.com/aspirin-omega-3-may-reduce-cancer-risk/ 2019-01-17T10:29:24+00:00 https://old.journalforclinicalstudies.com/danish-malaria-vaccine-passes-test-humans/ 2019-01-17T10:16:55+00:00 https://old.journalforclinicalstudies.com/clinigen-extends-exclusive-european-clinical-trial-sourcing-supply-agreement-accord-healthcare/ 2019-01-17T10:14:11+00:00 https://old.journalforclinicalstudies.com/new-england-journal-medicine-publishes-positive-results-pivotal-trial-cablivi-caplacizumab-rare-blood-clotting-disorder/ 2019-01-17T10:09:39+00:00 https://old.journalforclinicalstudies.com/carthera-obtains-ansm-approval-launch-phase-ii-clinical-trial-sonocloud-9-device-treatment-recurrent-glioblastoma/ 2019-01-17T10:07:06+00:00 https://old.journalforclinicalstudies.com/align-clinical-cro-publishes-new-operational-data-exchange-standard-life-sciences-industry-input/ 2019-01-17T10:00:38+00:00 https://old.journalforclinicalstudies.com/pfizer-initiates-phase-2b3-clinical-trial-pf-06651600-oral-jak3-inhibitor-treatment-patients-moderate-severe-alopecia-areata/ 2019-01-10T10:16:26+00:00 https://old.journalforclinicalstudies.com/lynparza-meets-primary-endpoint-phase-iii-solo-3-trial-treatment-relapsed-brca-mutated-advanced-ovarian-cancer/ 2019-01-10T10:14:53+00:00 https://old.journalforclinicalstudies.com/phase-3-trial-rova-t-second-line-therapy-advanced-small-cell-lung-cancer-halted/ 2019-01-10T10:12:45+00:00 https://old.journalforclinicalstudies.com/nanobiotix-md-anderson-cancer-center-announce-large-scale-comprehensive-clinical-collaboration-nbtxr3/ 2019-01-10T10:00:26+00:00 https://old.journalforclinicalstudies.com/clinical-trial-launches-develop-breath-test-multiple-cancers/ 2019-01-10T09:58:26+00:00 https://old.journalforclinicalstudies.com/north-estonia-medical-centre-joined-network-hospitals-clinerions-patient-network-explorer-platform/ 2019-01-10T09:57:14+00:00 https://old.journalforclinicalstudies.com/abbvie-jj-dominate-clinical-trial-development-psoriatic-arthritis-says-globaldata/ 2019-01-10T09:47:51+00:00 https://old.journalforclinicalstudies.com/pci-pharma-services-announces-20-million-expansion-biotech-technologies-including-advanced-injectable-delivery-forms/ 2019-01-07T16:57:25+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2019/01/PCI-Syringe-assembly-scaled.jpg https://old.journalforclinicalstudies.com/wp-content/uploads/2019/01/PCI-invests-in-automated-assembly-of-autoinjectors-300dpi.jpg https://old.journalforclinicalstudies.com/form-brain-training-may-help-treat-severe-schizophrenia/ 2018-12-20T10:15:38+00:00 https://old.journalforclinicalstudies.com/wu-biomedical-engineer-makes-significant-step-toward-precision-medicine/ 2018-12-20T10:11:32+00:00 https://old.journalforclinicalstudies.com/sutimlimab-shows-promise-hard-treat-rare-blood-disorder/ 2018-12-20T10:06:51+00:00 https://old.journalforclinicalstudies.com/first-line-immunotherapy-combination-fails-improve-overall-survival-lung-cancer/ 2018-12-20T10:05:04+00:00 https://old.journalforclinicalstudies.com/xbiotech-announces-publication-post-hoc-analysis-phase-iii-colorectal-cancer-study/ 2018-12-20T09:59:02+00:00 https://old.journalforclinicalstudies.com/minoryx-therapeutics-announces-early-completion-patient-randomization-advance-trial-phase-23-clinical-study-min-102-x-ald-patients/ 2018-12-20T09:55:51+00:00 https://old.journalforclinicalstudies.com/shivom-partners-lifebit-power-ai-analysis-dna-data-clinical-trials/ 2018-12-20T09:54:36+00:00 https://old.journalforclinicalstudies.com/asarina-pharma-scientific-advisory-board-gives-full-backing-menstrual-migraine-phase-iia-trial/ 2018-12-20T09:50:37+00:00 https://old.journalforclinicalstudies.com/pci-continues-invest-according-market-demand-specialist-2-8c-cold-chain-capabilities-become-operational-hay-wye-uk-site/ 2018-12-10T16:26:49+00:00 https://old.journalforclinicalstudies.com/pci-clinical-services-showcase-expertise-phase-clinical-trials-australia/ 2018-12-07T15:27:40+00:00 https://old.journalforclinicalstudies.com/pci-pharma-services-celebrates-success-aspire-blaenau-gwent-shared-apprenticeship-awards/ 2018-12-07T15:20:43+00:00 https://old.journalforclinicalstudies.com/car-t-cell-update-therapy-improves-outcomes-patients-b-cell-lymphoma/ 2018-12-06T10:23:43+00:00 https://old.journalforclinicalstudies.com/cannabis-based-compound-may-reduce-seizures-children-epilepsy/ 2018-12-06T10:20:57+00:00 https://old.journalforclinicalstudies.com/study-chemotherapy-agent-not-improve-survival-patients-triple-negative-breast-cancer/ 2018-12-06T10:18:52+00:00 https://old.journalforclinicalstudies.com/liraglutide-drug-associated-lower-risk-cardiovascular-events/ 2018-12-06T10:17:08+00:00 https://old.journalforclinicalstudies.com/idd-biotech-receives-second-milestone-payment-genmab-enrollment-fifth-patient-gen1029-hexabody-dr5dr5-safety-trial-patients-malignant-solid-tumors/ 2018-12-06T10:14:17+00:00 https://old.journalforclinicalstudies.com/wearable-technology-expand-electrophysiology-market-2-6bn-2028-says-globaldata/ 2018-12-06T10:13:18+00:00 https://old.journalforclinicalstudies.com/first-patient-successfully-implanted-implandatas-novel-eye-pressure-sensor-continual-glaucoma-monitoring/ 2018-12-06T09:53:58+00:00 https://old.journalforclinicalstudies.com/polyphor-announces-positive-results-fda-type-b-guidance-meeting-planned-phase-iii-study-balixafortide/ 2018-12-06T09:51:04+00:00 https://old.journalforclinicalstudies.com/botulinum-toxin-injections-show-promise-suppress-postoperative-atrial-fibrillation/ 2018-11-29T10:25:17+00:00 https://old.journalforclinicalstudies.com/new-antibody-can-reduce-swelling-attacks-patients-hereditary-angioedema/ 2018-11-29T10:11:53+00:00 https://old.journalforclinicalstudies.com/gel-formulation-new-male-contraceptive-trial/ 2018-11-29T10:08:24+00:00 https://old.journalforclinicalstudies.com/fda-approves-new-treatment-patients-acute-myeloid-leukemia/ 2018-11-29T09:55:09+00:00 https://old.journalforclinicalstudies.com/immune-regulation-announces-positive-results-phase-1-clinical-trial-pin201104/ 2018-11-29T09:46:49+00:00 https://old.journalforclinicalstudies.com/qps-expands-u-s-based-phase-clinical-trial-capabilities-support-growing-needs-pharmaceutical-biotechnology-sponsors/ 2018-11-29T09:45:08+00:00 https://old.journalforclinicalstudies.com/clinerion-upgrades-website-realtime-statistics-patient-network-explorer/ 2018-11-29T09:40:39+00:00 https://old.journalforclinicalstudies.com/biogen-scoops-sixth-prix-galien-award-uk-win-life-changing-rare-disease-medicine/ 2018-11-22T13:48:07+00:00 https://old.journalforclinicalstudies.com/3-hemophilia-patients-lift-uniqures-value-450m/ 2018-11-22T11:05:47+00:00 https://old.journalforclinicalstudies.com/fdas-woodcock-clinical-trial-system-broken/ 2018-11-22T10:26:03+00:00 https://old.journalforclinicalstudies.com/clinical-research-thrives-uk-figures-show-2/ 2018-11-22T10:20:54+00:00 https://old.journalforclinicalstudies.com/gamamabs-pharma-starts-phase-2-study-monoclonal-antibody-gm102-patients-advanced-metastatic-colorectal-cancer-2/ 2018-11-22T10:17:44+00:00 https://old.journalforclinicalstudies.com/breakthrough-treatment-peanut-allergy-awaits-fda-check/ 2018-11-22T10:10:24+00:00 https://old.journalforclinicalstudies.com/new-cancer-drug-safely-boosts-radiation-therapy-2/ 2018-11-22T10:06:18+00:00 https://old.journalforclinicalstudies.com/erytech-partners-new-york-blood-center-red-blood-cell-supply-research/ 2018-11-22T09:57:11+00:00 https://old.journalforclinicalstudies.com/quanticate-sponsors-research-response-adaptive-trial-design/ 2018-11-22T09:55:38+00:00 https://old.journalforclinicalstudies.com/restoring-sight-clinical-progress-towards-australias-bionic-eye/ 2018-11-22T09:54:17+00:00 https://old.journalforclinicalstudies.com/pci-clinical-services-announces-site-expansion-support-growth-flexibility-2/ 2018-11-19T15:58:15+00:00 https://old.journalforclinicalstudies.com/new-cancer-drug-safely-boosts-radiation-therapy/ 2018-11-15T10:11:35+00:00 https://old.journalforclinicalstudies.com/exuma-biotech-acquires-strategic-car-t-assets/ 2018-11-15T09:57:50+00:00 https://old.journalforclinicalstudies.com/dr-anthony-tolcher-joins-scientific-advisory-board-nbe-therapeutics/ 2018-11-15T09:53:20+00:00 https://old.journalforclinicalstudies.com/ionis-akcea-succeed-heart-drug-trial-setting-novartis-decision/ 2018-11-15T09:49:22+00:00 https://old.journalforclinicalstudies.com/super-responder-analysis-gives-power-vikings-fatty-liver-drug/ 2018-11-15T09:39:07+00:00 https://old.journalforclinicalstudies.com/sobi-snags-rights-astrazeneca-drugs-another-immunology-play/ 2018-11-15T09:36:08+00:00 https://old.journalforclinicalstudies.com/pci-clinical-services-announces-site-expansion-support-growth-flexibility/ 2018-11-15T09:28:34+00:00 https://old.journalforclinicalstudies.com/novartis-announces-clinical-collaboration-pfizer-advance-treatment-nash/ 2018-11-08T10:07:28+00:00 https://old.journalforclinicalstudies.com/chronic-inflammation-linked-increased-risk-multiple-diseases-shorter-lifespan/ 2018-11-08T10:05:53+00:00 https://old.journalforclinicalstudies.com/oral-antibiotic-shows-promise-cure-uncomplicated-gonorrhea/ 2018-11-08T09:52:28+00:00 https://old.journalforclinicalstudies.com/imcyse-successfully-completes-patient-enrollment-first-human-phase-1b-study-type-1-diabetes/ 2018-11-08T09:32:53+00:00 https://old.journalforclinicalstudies.com/sanofi-denali-therapeutics-develop-treatments-neurological-inflammatory-diseases/ 2018-11-08T09:31:29+00:00 https://old.journalforclinicalstudies.com/bavarian-nordic-announces-initiation-phase-2-trial-bn-brachyury-treatment-chordoma/ 2018-11-08T09:30:02+00:00 https://old.journalforclinicalstudies.com/pci-pharma-services-celebrates-significant-milestone-80-serialization-installations-across-global-supply-network/ 2018-11-06T16:02:38+00:00 https://old.journalforclinicalstudies.com/crf-health-crf-bracket-company-sees-first-class-ecoa-solutions-secure-15-global-dermatology-trials/ 2018-11-05T16:39:31+00:00 https://old.journalforclinicalstudies.com/high-impact-clinical-trial-results-affect-kidney-related-medical-care/ 2018-11-01T10:23:10+00:00 https://old.journalforclinicalstudies.com/study-highlights-accuracy-decisiondx-melanoma-prognostic-test-patients-stage-ii-iiia-melanoma/ 2018-11-01T10:17:52+00:00 https://old.journalforclinicalstudies.com/new-drug-kills-antibiotic-resistant-bacteria-clinical-trial/ 2018-11-01T10:10:24+00:00 https://old.journalforclinicalstudies.com/cristal-therapeutics-initiates-phase-2-clinical-trial-innovative-cripec-nanomedicine-drug-candidate-ovarian-cancer-2/ 2018-11-01T10:06:01+00:00 https://old.journalforclinicalstudies.com/retrospective-study-featuring-ossdsign-cranial-published-world-neurosurgery/ 2018-11-01T10:04:11+00:00 https://old.journalforclinicalstudies.com/pivotal-trial-confirms-long-term-safety-efficacy-iv-iron-dosing-strategy/ 2018-11-01T10:01:47+00:00 https://old.journalforclinicalstudies.com/genmab-announces-positive-topline-results-phase-iii-maia-study-daratumumab-front-line-multiple-myeloma/ 2018-11-01T09:54:47+00:00 https://old.journalforclinicalstudies.com/innovative-approaches-early-phase-first-human-clinical-trials/ 2018-10-25T12:40:20+00:00 https://old.journalforclinicalstudies.com/maintaining-compliance-throughout-manufacturing-move-merger/ 2018-10-25T12:27:19+00:00 https://old.journalforclinicalstudies.com/cyber-risks-life-sciences-industry/ 2018-10-25T09:40:30+00:00 https://old.journalforclinicalstudies.com/risk-assessment-considerations-cell-therapy-supply-chain/ 2018-10-25T09:33:51+00:00 https://old.journalforclinicalstudies.com/targeted-drugs-advanced-cancer-move-specialist-units-community-setting/ 2018-10-25T09:28:04+00:00 https://old.journalforclinicalstudies.com/immunotherapy-may-become-new-first-line-treatment-metastatic-colorectal-cancers/ 2018-10-25T09:26:26+00:00 https://old.journalforclinicalstudies.com/fda-approves-asthma-indication-dupixent-dupilumab/ 2018-10-25T09:24:46+00:00 https://old.journalforclinicalstudies.com/polyganics-initiates-first-human-trial-liqoseal-innovative-approach-dural-closure/ 2018-10-25T09:21:00+00:00 https://old.journalforclinicalstudies.com/genmab-announces-positive-topline-results-phase-iii-cassiopeia-study-daratumumab-front-line-multiple-myeloma/ 2018-10-25T09:19:46+00:00 https://old.journalforclinicalstudies.com/nanobiotix-positive-phase-ii-iii-results-nbtxr3-soft-tissue-sarcoma-presented-esmo/ 2018-10-25T09:17:41+00:00 https://old.journalforclinicalstudies.com/orion-bayer-completed-phase-iii-trial-darolutamide-patients-non-metastatic-castration-resistant-prostate-cancer-primary-endpoint-met/ 2018-10-25T09:13:05+00:00 https://old.journalforclinicalstudies.com/balixafortide-combination-eribulin-metastatic-breast-cancer-data-presented-esmo-2018-show-consistent-positive-trend-efficacy-endpoints-including-overall-survival/ 2018-10-25T09:11:53+00:00 https://old.journalforclinicalstudies.com/cristal-therapeutics-initiates-phase-2-clinical-trial-innovative-cripec-nanomedicine-drug-candidate-ovarian-cancer/ 2018-10-25T08:57:49+00:00 https://old.journalforclinicalstudies.com/pci-clinical-services-announces-new-facility-dedicated-clinical-trial-returns/ 2018-10-22T12:32:24+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2013/06/1.pdf https://old.journalforclinicalstudies.com/pci-pharma-services-completes-acquisition-sherpa-clinical-packaging/ 2018-10-22T12:31:09+00:00 https://old.journalforclinicalstudies.com/new-blood-test-pediatric-brain-tumor-patients-offers-safer-approach-surgical-biopsies/ 2018-10-18T09:30:15+00:00 https://old.journalforclinicalstudies.com/patients-thought-incurable-can-benefit-high-dose-radiation-therapy/ 2018-10-18T09:15:42+00:00 https://old.journalforclinicalstudies.com/yisheng-receives-approval-rabies-vaccine-clinical-study/ 2018-10-18T09:10:51+00:00 https://old.journalforclinicalstudies.com/nhs-high-throughput-clinical-research-centres-bring-substantial-benefits-patients/ 2018-10-18T09:09:37+00:00 https://old.journalforclinicalstudies.com/fiasp-effective-controlling-blood-sugar-levels-children-adolescents-living-type-1-diabetes-compared-conventional-insulin-aspart/ 2018-10-18T09:07:29+00:00 https://old.journalforclinicalstudies.com/dupixent-dupilumab-showed-positive-topline-results-two-phase-3-trials-patients-chronic-rhinosinusitis-nasal-polyps/ 2018-10-18T09:06:05+00:00 https://old.journalforclinicalstudies.com/servier-galapagos-announce-start-global-roccella-phase-2-clinical-trial-s201086glpg1972-osteoarthritis/ 2018-10-03T13:56:51+00:00 https://old.journalforclinicalstudies.com/study-using-dfmo-shows-positive-results-children-high-risk-neuroblastoma/ 2018-10-03T13:36:28+00:00 https://old.journalforclinicalstudies.com/abbvie-provides-update-phase-3-study-ibrutinib-blood-cancer-diffuse-large-b-cell-lymphoma-ongoing-ibrutinib-clinical-program/ 2018-10-03T13:33:13+00:00 https://old.journalforclinicalstudies.com/pivotal-clinical-trial-costs-estimated-19-million/ 2018-10-03T13:14:59+00:00 https://old.journalforclinicalstudies.com/human-clinical-trial-investigational-calcification-inhibitor-generates-promising-results/ 2018-10-03T13:07:12+00:00 https://old.journalforclinicalstudies.com/new-cancer-vaccine-may-tackle-her2-positive-tumors/ 2018-10-03T13:04:12+00:00 https://old.journalforclinicalstudies.com/blockchain-combat-type-2-diabetes-epidemic-india/ 2018-10-03T12:55:42+00:00 https://old.journalforclinicalstudies.com/catalent-selected-provide-oral-delivery-systems-gb-sciences-proprietary-parkinsons-disease-therapies/ 2018-10-03T12:52:57+00:00 https://old.journalforclinicalstudies.com/new-inflammatory-biomarker-predicts-elevated-thrombosis-risk-cancer-patients/ 2018-10-03T12:51:07+00:00 https://old.journalforclinicalstudies.com/new-phase-2-data-somapacitan-demonstrate-potential-efficacious-weekly-treatment-childhood-growth-hormone-deficiency/ 2018-10-03T12:49:20+00:00 https://old.journalforclinicalstudies.com/psychotropic-polypharmacy-common-alzheimers-disease/ 2018-10-03T12:47:07+00:00 https://old.journalforclinicalstudies.com/ryzodeg-offers-simpler-solution-daily-dosing-reduced-risk-nocturnal-hypoglycaemia-vs-insulin-glargine-u100-plus-insulin-aspart/ 2018-10-03T12:44:38+00:00 https://old.journalforclinicalstudies.com/people-diabetes-may-achieve-improved-glycaemic-control-tresiba-versus-glargine-u100-without-increase-hypoglycaemia/ 2018-10-03T12:42:47+00:00 https://old.journalforclinicalstudies.com/addressing-social-cultural-drivers-type-2-diabetes-key-treatment-prevention/ 2018-10-03T12:41:12+00:00 https://old.journalforclinicalstudies.com/malmo-based-analytical-services-provider-champions-compliance-epista-life-science-formpipe-life-science/ 2018-09-27T13:24:54+00:00 https://old.journalforclinicalstudies.com/lower-clinical-trial-enrollment-associated-relapse-risk-aya-leukemia-patients/ 2018-09-27T09:12:58+00:00 https://old.journalforclinicalstudies.com/novel-treatment-regimen-ischemic-stroke/ 2018-09-27T09:10:31+00:00 https://old.journalforclinicalstudies.com/quanticate-partners-cluepoints-offer-data-quality-oversight-capabilities/ 2018-09-27T09:06:42+00:00 https://old.journalforclinicalstudies.com/minoryx-therapeutics-raises-e21-3m-series-b-funding-round/ 2018-09-27T09:04:46+00:00 https://old.journalforclinicalstudies.com/fda-grants-myelo-therapeutics-orphan-drug-designation-myelo001-treatment-acute-radiation-syndrome/ 2018-09-27T09:03:27+00:00 https://old.journalforclinicalstudies.com/companies-join-forces-showcase-ai-algorithms-can-progressively-adopted-study-conduct-dpharm-2018/ 2018-09-27T09:01:32+00:00 https://old.journalforclinicalstudies.com/worldwide-clinical-trials/ 2018-09-26T10:59:46+00:00 https://old.journalforclinicalstudies.com/pci-csp-technologies-inc-announce-strategic-collaboration-breakthrough-activ-blistertm-solutions/ 2018-09-21T12:28:21+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2018/09/Activ-Blister-from-CSP-Technologies-1-scaled.jpg https://old.journalforclinicalstudies.com/pci-pharma-services-announces-agreement-acquire-sherpa-clinical-packaging/ 2018-09-21T11:03:37+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2018/09/PCI-Acquires-Sherpa-scaled.jpg https://old.journalforclinicalstudies.com/pci-announces-expansion-industry-leading-cold-chain-infrastructure-dedicated-40c-facility/ 2018-09-21T10:56:50+00:00 https://old.journalforclinicalstudies.com/wp-content/uploads/2018/09/PCI-Cold-Chain-facility-Rockford-IL-1-scaled.jpeg https://old.journalforclinicalstudies.com/alector-announces-initiation-phase-1-trial-al001-treating-frontotemporal-dementia/ 2018-09-20T09:16:58+00:00 https://old.journalforclinicalstudies.com/novel-clinical-trial-examine-cannabis-potential-treatment-essential-tremor/ 2018-09-20T09:15:15+00:00 https://old.journalforclinicalstudies.com/resveratrol-decreases-pain-severity-levels-inflammatory-biomarkers-osteoarthritis-patients/ 2018-09-20T09:13:25+00:00 https://old.journalforclinicalstudies.com/landmark-ms-trial-launches-uk/ 2018-09-20T09:10:47+00:00 https://old.journalforclinicalstudies.com/lancet-respiratory-medicine-publishes-first-phase-iii-trial-pt010-triple-combination-therapy-moderate-severe-chronic-obstructive-pulmonary-disease/ 2018-09-20T09:08:34+00:00 https://old.journalforclinicalstudies.com/study-finds-daily-aspirin-not-reduce-heart-attack-risk/ 2018-09-20T09:03:46+00:00